Form:Available in tablets, capsules, or as a topical product
And now the regulatory framework is working to catch up
Cagrilintide is an investigational amylin analog and is not approved by the FDA, EMA, or comparable regulators for any indication
BPC-157 accelerates fibroblasts recruitment, and blood supply into injured tissues, it promotes wound regeneration in tendons, ligaments, muscles and bones, which has been demonstrated in vitro and in vivo research on rat tendons
Description Contents: 70 mg total peptide blend (50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500) Appearance: Pale blue to off-white lyophilized powder Storage: Store frozen ( 20 C) for long-term storage
Entering a target dose of 1,000mcg (1.0mg) will show that 0.2mL, or 20 units on a U-100 syringe, is needed